Skip to main content
Top
Published in: Lung 3/2024

Open Access 07-05-2024 | Bronchial Asthma | RESEARCH

Airway and Systemic Immunoglobulin Profiling and Immune Response in Adult Asthma

Authors: Laura J. Walsh, Ashley Sullivan, Chris Ward, Eoin B. Hunt, Susan Lapthorne, Joseph A. Eustace, Liam J. Fanning, Barry J. Plant, Paul M. O’Byrne, John A. MacSharry, Desmond M. Murphy

Published in: Lung | Issue 3/2024

Login to get access

Abstract

Introduction

Immunoglobulins play a vital role in host immune response and in the pathogenesis of conditions like asthma. Therapeutic agents such as monoclonal antibodies target specific elements of the asthmatic inflammatory cascade. Decisions to utilize these medications are often based on systemic inflammatory profiling without direct insight into the airway inflammatory profile. We sought to investigate the relationship between immunoglobulin and cytokine profiles in the airway and systemic immune compartments of adult asthmatics.

Methods

Blood sampling and bronchoscopy with bronchoalveolar lavage (BAL) were performed in 76 well-defined adult asthmatics. Antibody and cytokine profiles were measured in both BAL and serum using ELISA and quantibody arrays.

Results

There was no relationship between BAL and serum levels of IgE. This is of significance in an asthma population. For some analytes, correlation analysis was significant (P < 0.05) indicating representativeness of our cohort and experimental setup in those cases. Nevertheless, the predictive power (r2) of the BAL-to-serum comparisons was mostly low except for TNF-α (r2 = 0.73) when assuming a simple (linear) relationship.

Conclusion

This study highlights the importance of sample site when investigating the roles of immunoglobulins and cytokines in disease pathogenesis and suggests that both localized and systemic immune responses are at play. The prescription of asthma monoclonal therapy is generally based on systemic evaluation of cytokine and immunoglobulin levels. Our research suggests that this approach may not fully reflect the pathophysiology of the disease and may provide insight into why some patients respond to these targeted therapies while others do not.
Appendix
Available only for authorised users
Literature
18.
go back to reference Prairie YT (1996) Evaluating the predictive power of regression models. Can J Fish Aquat Sci 53:490–492CrossRef Prairie YT (1996) Evaluating the predictive power of regression models. Can J Fish Aquat Sci 53:490–492CrossRef
23.
go back to reference Pillai P, Fang C, Chan Y-C, Shamji MH, Harper C, Wu S-Y et al (2014) Allergen-specific IgE is not detectable in the bronchial mucosa of nonatopic asthmatic patients. J Allergy Clin Immunol 133:1770–1772. e11CrossRefPubMed Pillai P, Fang C, Chan Y-C, Shamji MH, Harper C, Wu S-Y et al (2014) Allergen-specific IgE is not detectable in the bronchial mucosa of nonatopic asthmatic patients. J Allergy Clin Immunol 133:1770–1772. e11CrossRefPubMed
Metadata
Title
Airway and Systemic Immunoglobulin Profiling and Immune Response in Adult Asthma
Authors
Laura J. Walsh
Ashley Sullivan
Chris Ward
Eoin B. Hunt
Susan Lapthorne
Joseph A. Eustace
Liam J. Fanning
Barry J. Plant
Paul M. O’Byrne
John A. MacSharry
Desmond M. Murphy
Publication date
07-05-2024
Publisher
Springer US
Published in
Lung / Issue 3/2024
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-024-00699-x

Other articles of this Issue 3/2024

Lung 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine